Artrya secures UK, EU approvals for Salix
Within a week, ASX-listed medtech company Artrya received both regulatory approvals from the European Union and the United Kingdom for its Salix Coronary Anatomy product.
The AI-powered software identifies and analyses arterial plaque to diagnose coronary artery disease.
The recent certifications allow Artrya to market Salix in 28 EU member countries and...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
